Statement: the primary clinical trial requires patients to be identified with hormone receptor positive advanced breast cancer, and further, they should not have been subjected to any preceding therapy for this severe cancer
Primary_evidence: Inclusion Criteria:   Confirmed hormone receptor positive advanced breast cancer, postmenopausal women Exclusion Criteria:   Previous treatment for advanced breast cancer (previous treatment for early breast cancer is allowed).